Clearside Biomedical (NASDAQ:CLSD) reported its Q4 earnings results on Tuesday, March 12, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Clearside Biomedical beat estimated earnings by 11.0%, reporting an EPS of $-0.08 versus an estimate of $-0.09.
Revenue was up $6.01 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 2.0% drop in the share price the next day.
Here's a look at Clearside Biomedical's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -0.15 | -0.14 | -0.14 | -0.13 |
EPS Actual | -0.15 | -0.15 | -0.15 | -0.16 |
Revenue Estimate | 160K | 120K | 140K | 100K |
Revenue Actual | 859K | 1.02M | 4K | 330K |
To track all earnings releases for Clearside Biomedical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.